Abstract
Objective:
The purpose of this article is to illustrate the CT findings in patients with hepatic metastases from a gastrointestinal stromal tumor who were treated with STI-571.
Conclusion:
Hepatic metastases from gastrointestinal stromal tumors that respond to treatment with STI-571 can appear as near-cystic components with well-defined borders on contrast-enhanced CT. Most metastases became smaller. These metastases resemble simple cysts, but density measurements may differentiate them from one another.
Publication types
-
Clinical Trial
-
Randomized Controlled Trial
MeSH terms
-
Aged
-
Antineoplastic Agents / therapeutic use*
-
Cysts / diagnostic imaging
-
Enzyme Inhibitors / therapeutic use*
-
Female
-
Gastrointestinal Neoplasms / pathology*
-
Humans
-
Liver Neoplasms / diagnostic imaging*
-
Liver Neoplasms / drug therapy
-
Liver Neoplasms / secondary*
-
Male
-
Middle Aged
-
Omentum
-
Peritoneal Neoplasms / pathology
-
Protein-Tyrosine Kinases / antagonists & inhibitors*
-
Stomach Neoplasms / pathology
-
Tomography, X-Ray Computed
Substances
-
Antineoplastic Agents
-
Enzyme Inhibitors
-
Protein-Tyrosine Kinases